More Triple-Leveraged Biotech ETFs Come to Town
For over five years, the ProShares Ultrashort Nasdaq Biotechnology (NasdaqGM: BIS) and the ProShares Ultra Nasdaq Biotechnology (NasdaqGM: BIB) cornered the market…
biotech stocks
Preparing for Biotech ETF Retrenchment
Let’s quickly clarify that headline. We are not saying that a biotech bear market is imminent, nor are we endorsing the idea…
A New Biotech ETF Could Challenge Established Rivals
It has been a stellar run for the legacy biotechnology exchange traded funds. The legacy biotechnology ETFs, including the largest, the iShares…
New Leveraged Biotech ETF off to a Fast Start
It probably isn’t material for your 401(k), alright, it isn’t, but the newly minted Direxion Daily S&P Biotech Bull Shares (NYSEArca: LABU)…
Biotech Hedge Funds are hot, but Biotech ETFs are Hotter
It is no secret that investors love biotechnology stocks and the related exchange traded funds. That love extends to hedge funds, some…
An ETF for Hedge Funds’ Favorite Biotechs
It is not a secret that biotechnology stocks are beloved, nor is it a secret that hedge funds are among the investors…
Interesting Biotech ETF Additions on the Way
There are five major biotechnology exchange traded funds on the market today, each with its own nuances and spins on the high-flying…
Biotech ETFs Look to Build on Hot August Returns
It was a frequent event in the month of August. Throughout the month, daily checks of exchange traded funds making new all-time…
The Right ETF for Biotech Takeover Targets
The health care sector is often fertile ground for mergers and acquisitions activity and the biotechnology sub-industry is usually the epicenter of…